NCT07000786 EUmetriosis: Insights Into the Pathogenesis of Endometriosis
| NCT ID | NCT07000786 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Université Catholique de Louvain |
| Condition | Endometriosis |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-05-12 |
| Primary Completion | 2029-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-05-12 with a primary completion date of 2029-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study investigates epigenetic changes in menstrual effluent and plasma from women with endometriosis to identify potential non-invasive diagnostic biomarkers for the disease.
Eligibility Criteria
Inclusion Criteria: * Premenopausal * In spontaneous menstrual cycle (no hormonal treatments for the last 3 months) * Healthy or with a clear diagnosis of endometriosis via ultrasound, MRI or laparoscopy Exclusion Criteria: * HIV or Hepatitis positive * Pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07000786 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 56 Years, studying Endometriosis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07000786 currently recruiting?
Yes, NCT07000786 is actively recruiting participants. Contact the research team at marie-madeleine.dolmans@uclouvain.be for enrollment information.
Where is the NCT07000786 trial being conducted?
This trial is being conducted at Brussels, Belgium.
Who is sponsoring the NCT07000786 clinical trial?
NCT07000786 is sponsored by Université Catholique de Louvain. The trial plans to enroll 60 participants.